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for at least 24 hours. Significant relationships between echocar-Analysis of the effect of hemodialysis on peripheral and central
diographic parameters and pulse wave contour (PWC) vari-arterial pressure waveforms.
ables included pre-HD AGI and LVM (r 5 0.47, P , 0.001).Background. Arterial stiffening is very pronounced in renal
There was better correlation between LVM and derived predi-patients. Carotid artery stiffening is a powerful predictor of
alysis aortic systolic BP (r 5 0.56, P , 0.001) than measuredfuture cardiovascular mortality, and measures of arterial com-
brachial (peripheral) systolic BP (r 5 0.35, P 5 0.04). Patientspliance correlate much better with left ventricular mass (LVM)
whose waveform remained abnormal (AGI remained positive)in dialysis patients than does brachial artery blood pressure
after HD had a more dilated LV (LV-EDD 5 52.07 6 3.48(BP). The aim of our study was to describe the influence of a
mm) than did those patients for whom HD restored “normal”hemodialysis (HD) session on arterial cushioning function and
arterial hemodynamics (LV-EDD 46.86 6 4.06 mm, P , 0.05).to correlate the potential different types of behavior with echo-
Conclusions. A standard HD session profoundly affectedcardiographic derived parameters.
aortic BP waveform characteristics, with a reduction in waveMethods. Radial artery pressure waveforms were measured
and recorded noninvasively by applanation tonometry in 51 reflection in 88% of patients. However, restoration by HD of a
healthy patients on regular three times weekly HD. The data normal aortic waveform was unusual. Patients whose waveform
were then converted into aortic pressure waveforms using a remained abnormal after HD had larger more dilated LV
regression equation (SphymoCore apparatus). Measurements chambers than did those patients for whom HD restored “nor-
were done pre- and post-HD in order to ascertain the effect mal” arterial hemodynamics.
of a single HD session on arterial hemodynamics. The augmen-
tation index (AGI; the difference between early and late pres-
sure peaks divided by the pulse pressure amplitude) was used
Arterial hypertension is common in renal disease andas an index for vascular compliance. Reproducibility was as-
is linked to survival on dialysis in some series [1, 2]. Thesessed in 20 young healthy subjects by determining the aortic
pulse wave augmentation index twice from radial artery BP reasons for hypertension are diverse, including salt and
measurements one minute apart. Intraobserver error was 2.4%. water overload and also factors that operate indepen-
For 10 dialysis patients similarly studied, the intraobserver
dently of volume status [3]. Blood pressure (BP) levels,error was 1.6%.
especially when measured using ambulatory BP monitor-Results. AGI was correlated with subjects’ height (r 5 20.37,
P 5 0.009), weight (r 5 20.41, P 5 0.002), and BP levels: ing [4], are linked to left ventricular mass (LVM) in
radial systolic BP (r 5 0.33, P 5 0.018), radial diastolic BP (r 5 dialysis patients [5], and LVM increase has an unfavor-
0.29, P 5 0.036), and central systolic BP (r 5 0.51, P , 0.001). able effect on dialysis patient survival [6].
Comparing the pre- with the post-HD AGI values, four pat-
Blood pressure recordings are virtually always takenterns of evolution became apparent: (1) The AGI was negative
using the brachial artery, and brachial artery determina-before the HD session and became even more negative after-
ward (N 5 3 out of 51). (2) The AGI was positive before the tions are thought accurately to reflect BP throughout the
HD session but became negative after dialysis (N 5 19 out of arterial circulation. While mean BPs are indeed similar in
51). (3) The AGI was positive before the HD session and, different regional circulations, the systolic and diastolicalthough diminished afterward, remained positive (N 5 23 out
BPs vary considerably [7]. Pulse pressure is lowest inof 51). (4) The AGI was positive before the HD session and
healthy subjects in the proximal aorta and increases pro-increased afterward (N 5 6 out of 51). We also found that in
some patients, AGI remained at lower than predialysis levels gressively as more distal parts of the circulation are
reached [7, 8]. The interaction between incident and
retrograde (from small arterial branch sites) arterialKey words: dialysis, arterial stiffening, cardiovascular mortality, left
ventrical mass, hemodynamics, blood pressure. wave energy represents the major explanation of the
previously mentioned variability. The physical locationReceived for publication July 13, 1999
in the arterial tree of the summation point of these energ-and in revised form October 20, 1999
Accepted for publication January 21, 2000 ies is dependent in health on arterial length (closely
coupled to patient height), to arterial stiffness, and toÓ 2000 by the International Society of Nephrology
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Table 1. Demographic data for the full cohort of 51 patientswave-energy reflectance characteristics. The changes
included in this studyseen in pulse-wave contour with increasing age and in
Mean6SD Median Min Maxdisease states, such as hypertension and renal failure,
arise from increased arterial stiffness (faster pulse-wave Age years 41.3610.7 42.0 20 61
Gender M/F 28/23velocity) and increased energy reflection (small vessel
Weight kg 65.7613.5 66.2 21.2 99.0pathology) [9, 10]. This process of arterial stiffening is Height cm 166.567.7 167.0 151 181
very pronounced in renal patients [reviewed in 11]. Ca- Time on dialysis months 49.7627.7 41.0 12 121
Kt/V 1.3460.23 1.3 1.1 1.5rotid artery stiffening is a powerful predictor of future
Hematocrita % 29.566.6 28 22 46cardiovascular mortality [12]. Measures of arterial compli- Plasma total protein g/L 7.160.7 7.2 5.5 9.6
ance correlate much better with LV mass in dialysis pa-
Kt/V, urea kinetic modeling.
tients than does brachial artery BP [13]. The reasons for a11 patients on EPO
the significant loss of arterial elasticity in renal disease are
poorly understood, but may result from dyslipidemia, ex-
cess endothelin [14], and excessive vessel calcification [15].
echocardiography for clinical reasons, and about 25 wereIn health, hypertension and renal disease, arterial dis-
identified as being non-“echogenic.” From the remainingtensibility can be influenced favorably and unfavorably by
95 patients, 74 fulfilled the other inclusion criteria. Fifty-drugs [16, 17], even at doses that do not cause a measurable
one were invited to participate and were able to completechange in brachial artery BP. Angiotensin-converting
the study successfully.enzyme (ACE) inhibitors have the greatest potential of
all antihypertensives to induce a reduction in LV mass
Dialysis protocolper mm Hg BP reduction in essential hypertensives [18],
are one of very few interventions that can reduce LV Dialysis was performed three times weekly using five-
mass in dialysis patients [17], and have profoundly bene- hour treatments using Fresenius 4008E machines, blood
ficial effects on arterial hemodynamics and wave energy access by means of mature radial arteriovenous (AV)
reflection [19]. fistulae, blood flow rates at 300 to 350 mL/min, dialysate
The fact that even in dialysis patients with severe loss flow rates at 500 mL/min, and bath conductivity 135 mS,
of arterial cushioning function there can be—with appro- bath calcium 1.75 mmol/L, bath buffer bicarbonate. Diet
priate drug therapy—a rapid and sustained improvement comprised 50 mmol/L sodium and 1.2 g high-grade protein
in arterial function [11] prompted us to investigate per day. Fluid allowance was 750 mL per day. Antihyper-
whether a hemodialysis (HD) session, during which both tensive drugs were only employed if salt and water re-
the blood volume and the vasoactive hormonal profile striction and extended dialysis sessions failed to bring
change, would influence arterial hemodynamics. We chose predialysis BP lower than 150/90 mm Hg. All antihyper-
to use a new apparatus, validated in health and in many tensives were discontinued for 48 hours before the study
disease states, to allow for rapid, accurate and reproduc- dialysis sessions. No exogenous saline or other plasma
ible measurement and analysis of peripheral arterial expanders were used in the study dialysis sessions. The
waveforms, in order to derive proximal aortic wave- study dialysis session in all cases was the second midweek
forms, indices of reflected wave energy, and cardiac func- dialysis (Wednesday or Thursday session). Baseline demo-




Brachial artery BP was measured in all subjects in theThe study took place over a three-month period in a
nonfistula arm, after 10 minutes of supine rest, using asingle regional renal unit northeast of Romania. Fifty-
standard sphygmomanometer with a cuff circumferenceone stable chronic HD patients, all on dialysis for more
appropriate to the arm width (phase V Korotkoff soundthan three months, were enrolled for the study. Exclu-
for diastolic BP) and was calculated as the mean of twosion criteria were regular cardiovascular instability on
readings one minute apart. BP was measured 10 minutesdialysis (symptomatic dialysis hypotension requiring sa-
before connection to and 15 minutes after disconnectionline infusion occurring in greater than 5% of dialysis
from the dialysis machine.sessions over the preceding half year), major comorbid
Using the SphygmoCore pulse wave velocity apparatusconditions (for example, malignancy), recent (within three
(PWV Inc., Sydney, Australia), a Millar arterial pressuremonths) myocardial infarction or unstable angina, a his-
tonometer, and pulse wave analysis software packagetory of congestive cardiac failure, evidence of peripheral
(PWV Inc.), radial arterial waveform in the nonfistulavascular disease, recent (within three months) transient
arm was measured by applanation tonometry [20–22].ischemic attacks/cerebrovascular accidents, and diabetes
mellitus. All 120 patients on the unit were subjected to Briefly, with the arm carefully supported in an anatomi-
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Fig. 1. Representative pulse waveform from
a subject with normal brachial artery blood
pressure (BP) levels, and virtually normal aor-
tic function (AGI of 12%). Note the differ-
ence between the aortic and the radial BP
values and the waveforms.
cally neutral position and the wrist extended by about One key parameter derived from this waveform analy-
sis was the arterial augmentation index, which is calcu-10 degrees, a tonometer probe was pressed against the
radial artery as it passed over the head of the radius. lated as the systolic BP peak 2 minus systolic BP peak 1
divided by pulse pressure (systolic BP 2 diastolic BP;Real time pulse arterial waveform was displayed on a
laptop computer screen, and the signal intensity and Figs. 1 and 2). Compliant vessels, such as the aorta in
young healthy adults, generally result in negative aug-quality maximized by careful repositioning of the probe.
Built-in quality-control measures included achieving sig- mentation. As arterial stiffness increases and the rate of
antegrade energy propagation increases, augmentationnal amplitude of 100 arbitrary units and having ,5%
variance in both the pulse waveform beat-to-beat maxi- becomes positive. This is accentuated if more energy is
reflected back from peripheral arterial branching pointsmum amplitude and the diastolic energy waveform char-
acteristics. Thirty seconds of suitable quality cardiac cy- (increased reflection coefficient), and the timing of the
reflected energy wave is also affected by the rate ofcles (typically 40 cycles) were recorded and averaged
by the software. From this averaged composite radial propagation (increased with increased arterial stiffness).
Thus, AGI is a parameter that is determined by arterialwaveform ejection duration, diastolic duration, first and
second systolic pressure peak, radial artery augmen- pulse wave velocity and by wave reflection properties.
These measurements were taken by a single observer,tation index (discussed later in this article), and maxi-
mum rate of increase in BP in systole were derived. each over a minute and in duplicate, 10 minutes before
and 15 minutes after the standard HD study session. TheThe software analytical program also derived in real
time from the measured radial artery waveform an aortic same observer repeated the pulse waveform analysis 24
and 48 hours after the index dialysis session, in the ab-BP waveform using a validated transfer function algo-
sence of the administration of any antihypertensive drugsrithm [23, 24]. From the derived aortic BP waveform,
for that period.the ejection duration, diastolic duration, first and second
systolic pressure peak, and aortic augmentation index
Echocardiography(discussed later in this article) were also calculated as
described previously (Figures 1 and 2 show the typical Starting 10 to 14 hours after the end of the study dialysis
session, each patient underwent echocardiography studyradial and derived aortic arterial waveform traces used
in this study). (Toshiba SSA-340A echocardiography machine; Toshiba
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Fig. 2. Representative pulse waveform from
a subject showing raised brachial artery BP
levels and abnormal aortic function (AGI of
131%). Note the greater similarity between
the aortic and radial BP values and waveforms
compared with Figure 1.
Corporation, Tokyo, Japan) and venesection for determi- session. Stepwise multiple linear regression analysis was
performed using the augmentation index as the depen-nation of hematocrit, ionized plasma calcium, plasma phos-
dent variable. Two-tailed P , 0.05 was considered sig-phate, alkaline phosphatase, aspartate aminotransferase
nificant.(AST), alanine aminotransferase (ALT), and plasma al-
bumin.
Echocardiography was performed and videotaped, and
RESULTSthe following parameters were determined: LV interven-
Study populationtricular septum thickness (IVST), posterior wall thick-
ness (PWT), end-systolic diameter (ESD), end-diastolic Selected demographic, clinical, and laboratory charac-
diameter (EDD), left atrial diameter (LA), fractional teristics of the study group are presented in Table 1. The
shortening index (FSI), and mean velocity of circumfer- group average BP before the study dialysis session was
ential fiber shortening (MVCF). LV ejection time, LV systolic BP 140.9 6 21.2 over diastolic BP 91.0 6 14.6
end-systolic BP, and LV end-systolic wall tension were mm Hg. With antihypertensive medication being stopped
also measured or derived. Wall and chamber measure- for 48 hours (one interdialytic interval) before the study,
ments were normalized for body surface area to derive 20 patients had values greater than 140 mm Hg systolic
LVM index (LVMI). Analyses were performed by two BP or 90 mm Hg diastolic BP at the time of the study.
independent technicians who were blinded to patient Nineteen patients were regularly taking antihypertensive
information, and using videotape from the echocardiog- medication (11 patients treated with 1 drug, 7 patients
raphy sessions. by a combination of two drugs, and 1 required a combina-
tion of three drugs). Antihypertensive regimens had not
Statistics been changed for the last six months. All patient were
Intergroup PWC, BP data, and echo data were com- normotensive (that is, averaged predialysis BP values less
pared by two-tailed nonpaired t-tests. Significant differ- than 140/90 mm Hg) when taking medication for the
ences in proportions were assessed by the chi-square test. previous three months.
One-way analysis of variance was used for multiple com- The main predialysis PWC parameters for the entire
population are presented in Table 2.parisons of the AGI change with time, following the HD
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Table 3. Determinants of the augmentation indexTable 2. Details of derived aortic pulse pressure (PH),
augmentation (AG), the ratio of the second to the first
Parameter P rsystolic waveform peaks (P2/P1) and the derived parameter,
augmentation index (AGI) using pulse wave contour analysis Univariate regression
from applanation tonometry of the radial artery for the full cohort Height 50.011 520.35
of 51 patients included in the study Weight pre-HD 50.003 520.42
Brachial (peripheral)-SBP 50.018 50.33Mean6SD Min Max
Brachial (peripheral)-DBP 50.036 50.29
LV ejection time 50.003 50.41PH 41.35613.56 15 73
AG 9.9567.96 25.3 27.5 LV end systolic pressure ,0.001 50.49
LV period, heart rate derived ,0.001 50.59P2/P1 132.9625.7 85.5 183.5
AGI5AG/PH 21.48613.90 215 43.5 LVM ,0.001 50.47
EDD ,0.001 50.68Abbreviations are: PH, pulse pressure height; AG, augmentation; P2, second
ESD ,0.001 50.64systolic pulse peak; P1, first systolic pulse peak; P2/P1, ratio of P2 to P1.
SV (stroke volume) ,0.001 50.58
LV wall stress ,0.001 50.44
Multiple regression analysis
End systolic LV wall stress, P50.055, t51.97, beta50.63;
LVET period, P50.0069, t52.85, beta50.25;Coefficients of variability for
LV 2 EDD, P50.023, t52.36, beta50.41SphygmoCore-derived parameters
AGI is defined in Table 2 for the full cohort of 51 patients included in
In 20 young healthy volunteers, aortic pulse wave aug- the study. Linear regression analysis and multiple regression analysis used the
augmentation index as the independent variable.mentation index was derived twice from radial artery
BP measurements one minute apart. Intraobserver error
was 2.4%. For 10 dialysis patients similarly studied, the
intraobserver error was 1.6%, which was in keeping with P 5 0.002, r 5 0.41; diastolic BP, P , 0.001, r 5 0.45)
previous reports [22]. Also, a subgroup of six dialysis pa- and to the magnitude of fluid removal (of weight loss,
tients was studied twice by one observer while they were P 5 0.037, r 5 0.30). There was no relationship with
hospitalized, but with a gap of four hours between read- the change in heart rate, hydration status, as assessed
ings, at rest and without dialysis or hemodynamic drugs, indirectly by inferior vena cava (IVC) diameters pre-
in order to assess intraobserver reproducibility. The intra-
and post-HD, or changes in electrolytes (Ca11, K1,
observer error was 5.2%. Finally, when two Sphygmo-
PO432, and Na1).Core operators measured aortic pulse wave augmenta-
Considering that a negative AGI best approximates ation index in the 20 healthy subjects, again at one minute
compliant pulse wave (Figs. 1 and 2), we further analyzedapart, the calculated interobserver error was 3.5%.
two subpopulations: Cohort A in which dialysis restored/
maintained the normal pattern (that is, negative augmen-Factors influencing AGI as an index of
tation) of the aortic pulse waveform (groups 1 and 2 above);aortic compliance
and cohort B in which a positive AGI was recorded bothAlthough on univariate analysis the augmentation in-
before and after the dialysis session (groups 3 and 4).dex was significantly related to patients’ anthropometric
Cohorts A and B were also significantly distinct whendata, BP levels and cardiac echocardiographic parame-
evaluating the amplitude of change in AGI, expressedters, the only relevant determinants were the LV internal
as a percentage of the initial predialysis value (Fig. 3).diameter, LV wall stress, and the heart period by multi-
Demographic, biochemical, treatment, and echocardio-ple regression statistical analysis (Table 3).
graphic differences between cohorts A and B are shown
in Tables 4 and 5, with additional information given onInfluence of the hemodialysis session on AGI
the small group of patients (group 4), in which the aorticComparing the pre- with the post-HD AGI values,
augmentation index was increased immediately after di-four patterns of evolution became apparent: (1) In one
alysis compared with predialysis values. Patients with angroup the AGI was negative before the HD session and
abnormal (persistently positive) postdialytic pattern ofbecame even more negative afterwards (N 5 3 out of 51
vascular compliance had significantly larger hearts, al-patients). (2) In the second group, the AGI was positive
though the systolic function was almost identical. LVbefore the HD session but became negative after dialysis
wall thickness was also similar between cohorts A and B.patients (N 5 19 out of 51). (3) In a third group the
Figure 4 shows the evolution of change in pulse wave-AGI was positive before the HD session and, although
form characteristics in the subsequent 48-hour interdia-diminished afterward, it remained positive (N 5 23 out
lytic interval. AGI values around an index dialysis ses-of 51). (4) Finally, the AGI was positive before the HD
sion for the cohort A subjects were 14.3 6 14.7 at 210session and increased afterward in 6 out of 51 patients.
minutes, 215.3 6 210.6 at 15 minutes (P , 0.001), 2.4 6The magnitude of change in AGI following the dialysis
212.3 at 24 hours (P , 0.05), and 15.2 6 29.6 (P 5 NS)session, as expressed as the percentage of the baseline
value, was related to BP levels before HD (systolic BP, at 48 hours. Similarly timed AGI values for the cohort
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renal disease and dialysis that could impinge on arterial
structure and function include atherosclerosis and arte-
riosclerosis [28], vessel calcification [15] dyslipidemia
[14], high circulating endothelin levels [14], dysautono-
mia [29, 30], and chronic salt/water overload [31]. Cer-
tainly, it has been shown that endothelial function is
measurably improved by HD in a way that is consistent
with the removal of circulating inhibitors of nitric oxide
synthase [32].
Our study demonstrated that despite adequate bra-
chial artery BP control, there were significant abnormali-
ties of arterial cushioning function (as reflected by the
AGI) in this dialysis cohort. Moreover, it was not possi-
ble to predict aortic hemodynamic responses following
a dialysis session from brachial artery BP measurements.Fig. 3. Changes in the augmentation index (AGI) following the hemo-
dialysis (HD) session. Subjects regaining a normal waveform profile This confirms other investigators’ findings using a similar
post-HD (cohort A) had a significantly greater amplitude of change in methodological approach. Saba et al used the same cut-AGI (P , 0.005) than did subjects with a persistent abnormal profile
off value, that is, an AGI of zero to differentiate between(cohort B). Changes in AGI are expressed as the % change from the
baseline pre-HD corresponding AGI value. normal compliance function (AGI , zero) and reduced
compliance function (AGI . zero) [33]. Using this crite-
rion, 95% of our dialysis cohort had abnormal arterial
behavior before HD, and 55% retained that abnormality
B subjects were 26.9 6 10.6 at 210 minutes, 16.0 6 28.4 after HD. Overall, in 88% of cases, there was some im-
at 15 minutes (P , 0.05), 24.3 6 211.2 at 24 hours (P 5 provement in arterial hemodynamics as a result of HD.
NS), and 27.2 6 210.8 at 48 hours (P 5 NS). In contrast From our results, we hypothesize that dialysis im-
to the marked aortic pulse waveform differences be- proves vascular compliance by removing vasoconstrict-
tween the cohorts of subjects in the interdialytic interval ing factors or by inducing the elaboration of vasodilating
of 48 hours (Fig. 4), we found that at each time point, factors. The difference in the amplitude of the AGI change
there was no statistically significant difference between pre- versus post-HD might be explained by the presence
measured brachial artery systolic and diastolic BP values of profound vascular structural damage (vascular calcifi-
between cohort A and cohort B subjects. cations) in the 55% of the subjects who still retain an
Significant relationships between echocardiographic abnormal compliance profile after the dialysis session.
parameters and PWV variables have been described in Possible alternative explanations were also considered
the section dealing with AGI determinants (Fig. 5 shows but thought unconvincing, including the physicochemical
the relationship between pre-HD AGI and LVM, r 5 properties of the arterial tree and blood circulation.
0.47, P , 0.001). There was better correlation between Thus, a shorter cardiac cycle as a result of tachycardia
LV mass and derived predialysis aortic systolic BP (r 5 induced by dialysis may dramatically change the pattern
0.56, P , 0.001) than measured brachial (peripheral) of the waveforms, but all the subjects were studied 15
systolic BP (r 5 0.35, P 5 0.04). minutes after disconnection from the dialysis machines,
and the recorded difference in pulse rates before and
after dialysis were not large enough to have a significantDISCUSSION
impact on augmentation. Also, a reduction in large arte-
Pulse waveform energy contour analysis, formerly only rial diameter by ultrafiltration—analogous to left heart
of historic interest [25], is now increasingly used as a cavity volume changes—returning the degree of stretch
technique to investigate large arterial cushioning function of the arterial wall to a more favorable part of the stretch-
and wave reflected energy. When the pulse waveform tension hysteresis curve may have an impact on arterial-
information can be obtained rapidly and noninvasively, cushioning function, although we could show no relation-
this becomes a powerful tool to investigate the cardiovas- ship with IVC diameter or with ultrafiltration volume.
cular response to different disease states and drugs. The reduction in BP after dialysis, which though present,
Previous reports have shown marked abnormality of was small and again not related to the degree of improve-
arterial compliance in dialysis patients [26], the underly- ment in augmentation was not likely to be an important
ing reasons for which are uncertain. Acute (after one dose) confounding factor, especially when one considers the
and chronic (after months of therapy) improvements in remarkable dissociation between aortic pulse waveform
these parameters can be induced using ACE inhibitors characteristics and brachial BP levels in the interdialytic
interval, where a marked difference in evolution of AGIin hypertensive [27] and dialysis [17] patients. Factors in
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Table 4. Comparison between patients with different patterns of change in aortic pulse waveform profile following the hemodialysis session:
Demographic, biochemical, treatment and blood pressure data
Cohort A Cohort B Group D
(N522) (N529) (N56)
Demographic parameters
M/F 15/7 13/16 3/3
Age years 40.1611.1 42.3610.5 40.866.9
Weight kg 71.2613.5 61.4612.0a 65.6619.5
Height cm 169.867.7 163.966.8a 163.767.6a
BSA m2 1.81960.200 1.67660.188a 1.76260.270
Dialysis parameters
Time on dialysis months 45.7628.0 52.7627.5 56.2619.5
Kt/V 1.3562.1 1.3361.9 1.3860.8
Weight loss
kg 3.061.1 2.661.2 2.761.93
% pre-HD weight 4.361.2 4.161.5 3.8561.67
Conductivity mS 139.262.2 140.062.5 139.063.74
Hematocrit % 30.167.2 29.166.1 31.564.5
Total protein g/L 6.9360.68 7.2060.75 7.1660.75
Blood pressure data
Radial pre-HD SBP/DBP mm Hg 141.7621.7/88.9616.6 138.8622.3/83.4613.3 124.6622.3/78.4610.3
Central pre-HD SBP/DBP mm Hg 126.9622.0/88.5613.9 128.9622.0/85.3613.8 113.2618.5/77.8610.4
Radial post-HD SBP/DBP mm Hg 125.0625.7/74.6612.2 130.4624.3/78.8613.2 118.8633.3/75.869.2b
Central post-HD SBP/DBP mm Hg 105.1619.6/76.6612.6 117.3621.8/80.1613.8a 108.4629.7/74.7618.9
Antihypertensives
% patients 40.9 34.5 30
% patients on .1 drug 22.7 10.3 30
% patients on ACE-I 36.4 10.3a 16.6
Abbreviations are: BSA, body surface area; Kt/V, derived Kt/V (urea); LV, left ventricle; EDD, end-diastolic LV diameter; ESD, end-systolic LV diameter; IVST,
interventricular septal thickness; PWT, LV posterior wall thickness; EDD/PWT, asymmetrical hypertrophy measurement; LVM, LV mass; LVMI, LV mass indexed
for BSA; FSI, fractional shortening index; MVCF, mean velocity of circumferential fiber shortening; ESP-End systolic press, end-systolic LV pressure; ESP/PWT,
measure of LV wall tension; IVC, inferior vena cava (width).
Cohort A is defined as patients in whom dialysis restores a normal aortic pulse waveform pattern; Cohort B comprise patients with a persistent abnormal aortic
pulse waveform pattern following dialysis.
Group D is a subgroup of patients in which the AGI increases following the hemodialysis session.
aSignificant difference (P , 0.05) from corresponding cohort A value
bSignificant difference (P , 0.05) from corresponding cohort B value
Table 5. Comparison between patients with different patterns of change in aortic pulse waveform profile following the hemodialysis session:
Echocardiographic evaluation
Cohort A Cohort B Group D
(N522) (N529) (N56)
EDD mm 46.8864.06 52.0763.48a 53.861.5a
ESD mm 31.2363.63 34.562.95a 33.961.6a
IVST mm 12.0561.17 11.5561.21 11.5061.37
PWT mm 11.9561.25 11.8661.26 11.8161.47
EDD/PWT 3.9560.48 4.4360.51a 4.660.53a
LVM g 252.01654.09 289.27655.14a 303.1650.9a
LVMI g/m2 139.87633.9 174.40638.64a 176.9647.5a
FSI % 33.456 3.23 33.763.89 37.162.75a,b
MVCF %/ms 0.11660.019 0.11060.016 0.12860.013
End systolic press mm Hg 115.19619.0 116.26619.17 103.75615.6
ESP/PWT mm Hg/mm 9.70361.679 9.86661.736 8.81461.34
Ejection duration ms 294.9654.9 309.02629.3 291.6644.6
Stroke volume mL 63.3611.5 80.9613.9a 93.268.2a,b
IVC mm 18.963.4 19.464.1 19.862.5
Abbreviations are: BSA, body surface area; Kt/V, derived Kt/V (urea); LV, left ventricle; EDD, end-diastolic LV diameter; ESD, end-systolic LV diameter; IVST,
interventricular septal thickness; PWT, LV posterior wall thickness; EDD/PWT, asymmetrical hypertrophy measurement; LVM, LV mass; LVMI, LV mass indexed
for BSA; FSI, fractional shortening index; MVCF, mean velocity of circumferential fiber shortening; ESP-end systolic press, end-systolic LV pressure; ESP/PWT,
measure of LV wall tension; IVC, inferior vena cava (width).
Cohort A is defined as patients in whom dialysis restores the normal aortic pulse waveform pattern; Cohort B comprises patients with a persistent abnormal aortic
pulse waveform pattern following dialysis.
Group D is the subgroup of patients in which the AGI increases following the hemodialysis session.
aSignificant difference (P , 0.05) from corresponding cohort A value
bSignificant difference (P , 0.05) from corresponding cohort B value
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Fig. 5. Relationship between AGI and LVM. This figure shows the
close relationship (r 5 0.47, P , 0.001) between echocardiographically
Fig. 4. Evolution of AGI in the interdialytic interval. Subjects from measured LV mass and the value of the aortic augmentation index
cohort A (those whose aortic augmentation index was restored to nor- measured just before dialysis.
mal by HD) showed a much greater change in aortic AGI comparing
values 10 minutes before HD to 15 minutes after HD. Moreover, the
normalization of the aortic waveform was evident even 24 hours after
dialysis, whereas subjects from cohort B, in which HD did not restore made to determine whether the dialysis-induced alter-normal aortic waveforms, not only started from a higher (that is, more
ation in AGI that we describe comes about because ofabnormal) aortic AGI, but the small change brought about by HD was
lost at 24 hours, where aortic AGI values were the same as predialysis decreased arterial stiffness (increased arterial compli-
AGI values. For both cohorts, aortic AGI values were very similar to ance) or because of a change in the wave energy reflec-predialysis levels 48 hours later, that is, just before the next dialysis
tion coefficient (both of which determine AGI).session. #Cohort B AGI significantly different compared with pre-HD
values (one-way ANOVA). **Cohort A AGI significantly different Our data reveal a much closer relationship between
compared with pre-HD values (one-way ANOVA). derived aortic, rather than measured brachial, predialysis
systolic BP and LV mass (r 5 0.56, P , 0.001, compare
r 5 0.35, P 5 0.04). London et al showed that aortic
pulse wave velocity was able to explain much more ofwith time was seen between the more “reactive” cohort
A patients and the less “reactive” cohort B patients (Fig. the variance in LVM than could brachial BP [11]. More
important, we have also showed that subjects whose aug-4), while brachial BP values were similar comparing
these two cohorts over that same interdialytic interval. mentation index remained positive (that is, abnormal)
even after dialysis (cohort B; Results section) had largerFinally, altered cardiac inotropism following the dialysis
session was excluded, as there was no baseline echocardi- hearts than those subjects whose augmentation index
“normalized” with dialysis (cohort A). As shown in Fig-ographic demonstration of poor systolic LV function and
no consistent change pre- to postdialysis of the initial ure 4, these cohort B subjects with the highest augmen-
tation indices, in whom HD was not able to restorerate of rise of BP in the first part of cardiac systole after
aortic valve opening (dP/dt; data not shown). hemodynamics to normal, returned to their predialysis
AGI values before 24 hours after HD, compared with theThere is likely to be a complex interplay between
both functional and structural components of increased normalized cohort A, in whom the 24-hour postdialysis
augmentation index was still significantly lower than thearterial stiffness and factors determining the speed and
extent of reflected wave energy in the circulation. Angio- predialysis augmentation index. In this context, LV wall
stress would be higher for a longer period of time in thetensin-converting enzyme (ACE) inhibitors in previous
studies have been to shown to reduce wave reflection cohort B subjects, and this may explain their tendency
for greater LV mass. It is also of interest that significantly[17], and clearly, the greater proportional use of ACE
inhibitors in the more favorable cohort we describe may fewer patients in this less favorable cohort B cohort
(higher predialysis AGI, less reduction with HD, greaterhave contributed to this observation. Our study was not
designed to find the explanation for these phenomena, LVM) were on ACE inhibitors, and that patients in this
cohort were significantly shorter of stature (lack of heightbut clearly, these and other possible mechanisms can be
investigated in future studies. Using a more sophisticated meaning that the pulse wave has less distance to travel
to and from the proximal aorta, which for any givenversion of the SphygmoCore apparatus, it is possible
to measure aortic pulse wave velocity as well as aortic aortic pulse wave velocity would mean earlier/greater
wave reflection in shorter patients). Patients with higheraugmentation index directly. Thus, an attempt could be
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